Literature DB >> 6952254

Defective spectrin dimer-dimer association with hereditary elliptocytosis.

S C Liu, J Palek, J T Prchal.   

Abstract

We examined erythrocytes from 18 patients with hereditary elliptocytosis. Spectrin from eight patients (referred to as type 1) was defective in dimer-dimer association as demonstrated in two ways. First, there was an increased amount of spectrin dimer with a concomitant decrease in tetramer as measured in erythrocyte membrane preparations extracted at 0 degrees C under low-salt conditions (the amount of spectrin dimer was 15-33% of total spectrin species compared with a normal range of 3-7%). Second, the equilibrium constants of spectrin dimer-dimer association were decreased in both solution and in situ membrane. Spectrin from the remaining 10 patients (referred to as type 2) showed normal dimer-dimer association. Membrane skeletons, produced from ghosts of both types of hereditary elliptocytosis by Triton X-100 extraction, were unstable when mechanically shaken. Because spectrin tetramers, but not dimers, can crosslink actin, we postulate that the defective spectrin dimer-dimer association in type 1 diminishes actin crosslinking and thus is responsible for membrane skeletal instability. A defective protein-protein association in type 2, however, remains to be identified.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6952254      PMCID: PMC346125          DOI: 10.1073/pnas.79.6.2072

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Spontaneous, reversible protein cross-linking in the human erythrocyte membrane. Temperature and pH dependence.

Authors:  S C Liu; G Fairbanks; J Palek
Journal:  Biochemistry       Date:  1977-09-06       Impact factor: 3.162

Review 2.  Spectrin-actin membrane skeleton of normal and abnormal red blood cells.

Authors:  S E Lux
Journal:  Semin Hematol       Date:  1979-01       Impact factor: 3.851

3.  Spectrin-actin interaction. Phosphorylated and dephosphorylated spectrin tetramer cross-link F-actin.

Authors:  S L Brenner; E D Korn
Journal:  J Biol Chem       Date:  1979-09-10       Impact factor: 5.157

4.  The temperature-dependent dissociation of spectrin.

Authors:  G Ralston; J Dunbar; M White
Journal:  Biochim Biophys Acta       Date:  1977-03-28

5.  Spectrin tetramer-dimer equilibrium and the stability of erythrocyte membrane skeletons.

Authors:  S C Liu; J Palek
Journal:  Nature       Date:  1980-06-19       Impact factor: 49.962

6.  Self-association of human spectrin. A thermodynamic and kinetic study.

Authors:  E Ungewickell; W Gratzer
Journal:  Eur J Biochem       Date:  1978-08-01

7.  Identification of functional domains of human erythrocyte spectrin.

Authors:  J S Morrow; D W Speicher; W J Knowles; C J Hsu; V T Marchesi
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

8.  In vitro formation of a complex between cytoskeletal proteins of the human erythrocyte.

Authors:  E Ungewickell; P M Bennett; R Calvert; V Ohanian; W B Gratzer
Journal:  Nature       Date:  1979-08-30       Impact factor: 49.962

9.  The molecular structure of human erythrocyte spectrin. Biophysical and electron microscopic studies.

Authors:  D M Shotton; B E Burke; D Branton
Journal:  J Mol Biol       Date:  1979-06-25       Impact factor: 5.469

10.  Spectrin plus band 4.1 cross-link actin. Regulation by micromolar calcium.

Authors:  V Fowler; D L Taylor
Journal:  J Cell Biol       Date:  1980-05       Impact factor: 10.539

View more
  20 in total

1.  Spectrin folding versus unfolding reactions and RBC membrane stiffness.

Authors:  Qiang Zhu; Robert J Asaro
Journal:  Biophys J       Date:  2007-12-07       Impact factor: 4.033

2.  Immunocytochemical study of membrane skeletons in abnormally shaped erythrocytes as revealed by a quick-freezing and deep-etching method.

Authors:  S Ohno; N Terada; Y Fujii; H Ueda; H Kuramoto; N Kamisawa
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

3.  Deficiency of protein 4.2 in erythrocytes from a patient with a Coombs negative hemolytic anemia. Evidence for a role of protein 4.2 in stabilizing ankyrin on the membrane.

Authors:  A C Rybicki; R Heath; J L Wolf; B Lubin; R S Schwartz
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

4.  The spectrin network as a barrier to lateral diffusion in erythrocytes. A percolation analysis.

Authors:  M J Saxton
Journal:  Biophys J       Date:  1989-01       Impact factor: 4.033

5.  Unique alpha-spectrin mutant in a kindred with common hereditary elliptocytosis.

Authors:  P A Lane; R L Shew; T A Iarocci; N Mohandas; T Hays; W C Mentzer
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

6.  Four different mutations in codon 28 of alpha spectrin are associated with structurally and functionally abnormal spectrin alpha I/74 in hereditary elliptocytosis.

Authors:  T L Coetzer; K Sahr; J Prchal; H Blacklock; L Peterson; R Koler; J Doyle; J Manaster; J Palek
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

7.  A common type of the spectrin alpha I 46-50a-kD peptide abnormality in hereditary elliptocytosis and pyropoikilocytosis is associated with a mutation distant from the proteolytic cleavage site. Evidence for the functional importance of the triple helical model of spectrin.

Authors:  P G Gallagher; W T Tse; T Coetzer; M C Lecomte; M Garbarz; H S Zarkowsky; A Baruchel; S K Ballas; D Dhermy; J Palek
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

8.  Defective binding of spectrin to ankyrin in a kindred with recessively inherited hereditary elliptocytosis.

Authors:  S S Zail; T L Coetzer
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

9.  A molecular defect of spectrin in a subset of patients with hereditary elliptocytosis. Alterations in the alpha-subunit domain involved in spectrin self-association.

Authors:  J Lawler; S C Liu; J Palek; J Prchal
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

10.  Serum iron, total iron binding capacity, plasma copper and hemoglobin types in anemic and poikilocytic calves.

Authors:  S R McGillivray; G P Searcy; V M Hirsch
Journal:  Can J Comp Med       Date:  1985-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.